A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204)

• Gavin J. Churchyard ,

  * E-mail: gchurchyard@auruminstitute.org

  Affiliations Aurum Institute for Health Research, Klerksdorp, South Africa, Centre for AIDS Programme of Research in South Africa (CAPRISA), University of Kwa-Zulu Natal, Durban, South Africa

  ⨯
• Cecilia Morgan,

  Affiliation Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Elizabeth Adams,

  Affiliation Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Health (NIH), Bethesda, Maryland, United States of America

  ⨯
• John Hural,

  Affiliation Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Barney S. Graham,

  Affiliation Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, United States of America

  ⨯
• Zoe Moodie,

  Affiliation Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Doug Grove,

  Affiliation Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Glenda Gray,

  Affiliation Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Linda-Gail Bekker,

  Affiliation Desmond Tutu HIV Foundation, University of Cape Town, Cape Town, South Africa

  ⨯
• M. Juliana McElrath,

  Affiliation Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Georgia D. Tomaras,

  Affiliation Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Paul Goepfert,

  Affiliation University of Alabama, Birmingham, Alabama, United States of America

  ⨯
• Spyros Kalams,

  Affiliation Vanderbilt University, Nashville, Tennessee, United States of America

  ⨯
• Lindsey R. Baden,

  Affiliation Harvard-Brigham and Women's Hospital, Boston, Massachusetts, United States of America

  ⨯
• Michelle Lally,

  Affiliation Alpert Medical School of Brown University and Miriam Hospital, Providence, Rhode Island, United States of America

  ⨯
• Raphael Dolin,

  Affiliation Harvard Medical School- Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America

  ⨯
• William Blattner,

  Affiliation University of Maryland, College Park, Maryland, United States of America

  ⨯
• Artur Kalichman,

  Affiliation Centro de Referencia e Treinamento em DST/AIDS, Coordenacao dos Institutos de Pesquisa, San Paulo, Brazil

  ⨯
• J. Peter Figueroa,

  Affiliation Epidemiology Research and Training Unit (ERTU), Kingston, Jamaica

  ⨯
• Jean Pape,

  Affiliation Cornell-GHESKIO, Institut National de Laboratoire et de Recherches, Port au Prince, Haiti

  ⨯
• Mauro Schechter,

  Affiliation Projeto Praça Onze, Hospital Escola São Francisco de Assis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

  ⨯
• Olivier Defawe,

  Affiliation Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Stephen C. De Rosa,

  Affiliation Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• David C. Montefiori,

  Affiliation Duke Human Vaccine Institute, School of Medicine, Duke University, Durham, North Carolina, United States of America

  ⨯
• Gary J. Nabel,

  Affiliation Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, United States of America

  ⨯
• Lawrence Corey,

  Affiliation Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Michael C. Keefer,

  Affiliation Department of Medicine, University of Rochester School of Medicine & Dentistry, Rochester, New York, United States of America

  ⨯
•  [ ... ],
• and the NIAID HIV Vaccine Trials Network
• [ view all ]
• [ view less ]